Ghosh mrinal k (4 Ergebnisse)

Sprache: Englisch
Verlag: Cambridge University Press 2012
Serie: Encyclopedia of Mathematics and its Applications, Buch 143 von 188. Buch 143 von 188 - Encyclopedia of Mathematics and its Applications
- Hardcover
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes KönigreichRia Christie Collections
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 138,70
EUR 13,86 VersandVersand von Vereinigtes Königreich nach USAAnzahl: Mehr als 20 verfügbar
Zustand: New. In.

Sprache: Englisch
Verlag: Cambridge Univ Pr 2011
Serie: Encyclopedia of Mathematics and its Applications, Buch 143 von 188. Buch 143 von 188 - Encyclopedia of Mathematics and its Applications
- Hardcover
Anbieter: Revaluation Books, Exeter, , Vereinigtes KönigreichRevaluation Books
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 192,56
EUR 14,47 VersandVersand von Vereinigtes Königreich nach USAAnzahl: 2 verfügbar
Hardcover. Zustand: Brand New. 1st edition. 335 pages. 9.75x6.75x1.00 inches. In Stock.

- Hardcover
Anbieter: AHA-BUCH GmbH, Einbeck, DeutschlandAHA-BUCH GmbH
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 223,11
EUR 64,60 VersandVersand von Deutschland nach USAAnzahl: 1 verfügbar
Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book offers a definitive and comprehensive exploration of precision medicine, capturing both its foundational principles and cutting-edge innovations. Organized into six sections, it guides readers from the basics of individualized healthcare to the ad…vanced application of genomics, epigenomics, pharmacogenomics, and artificial intelligence in cancer treatment. Through detailed cancer-specific chapters covering gliomas, head & neck cancers, breast, lung, prostate, colon, pancreatic, and other malignancies the book delivers in-depth insights into molecular profiling, diagnosis, and personalized therapy strategies. Beyond scientific advances, it critically addresses the ethical, clinical, and social dimensions of precision medicine, preparing clinicians, researchers, and policymakers to navigate challenges and harness the future opportunities in this transformative field. By blending scientific rigor with forward-looking perspectives, this volume positions itself as an authoritative reference for oncology researchers, clinicians, bioinformaticians, pharmaceutical scientists, and graduate students seeking to understand and contribute to the future of personalized healthcare.

- Hardcover
Anbieter: AHA-BUCH GmbH, Einbeck, DeutschlandAHA-BUCH GmbH
Verkäufer/-in kontaktierenVerkäufer/-in mit 5 SternenZustand: Neu
EUR 225,03
EUR 65,49 VersandVersand von Deutschland nach USAAnzahl: 1 verfügbar
Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book provides up-to-date insights into the COVID-19 disease, addressing its outbreak, pathogenesis, biology, treatment interventions, and consequences as a global health crisis. Divided into six sections, the book covers a detailed examination of vario…us facets of the disease. Section I delves into the host's genetic and epigenetic mechanisms in response to COVID-19. Section II focuses on disease diagnosis, providing valuable perspectives on kits, nucleic acid testing, immunological assays, imaging-based diagnosis, and variant-specific SARS-COV-2 detection. Section III covers cytokine storm, inflammation, and immunity, including the modulation of signaling pathways leading to immune evasion and persistence. Section IV reveals drug repurposing, exploring antiviral, anti-inflammatory, anti-platelet drugs, and target-based drug discovery. Section V explains the evolution of vaccine development including DNA, RNA, subunit, and viral vaccines. Finally, Section VI explores COVID-19's impact on associated comorbidities, ranging from cancer and cardiac issues to neurological damages and economic consequences.The book is relevant for scientists, and researchers working on pathogenesis, development, implementation, host-pathogen interactions, and drug repurposing of COVID-19 disease.